{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:27:26Z","timestamp":1790663246904,"version":"4.1.0"},"reference-count":58,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T00:00:00Z","timestamp":1598140800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["PRELUDIUM (2018\/31\/N\/NZ7\/02260)"],"award-info":[{"award-number":["PRELUDIUM (2018\/31\/N\/NZ7\/02260)"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Platelet extracellular vesicles (PEVs) are potential new biomarkers of platelet activation which may allow us to predict and\/or diagnose developing coronary thrombosis before myocardial necrosis occurs. The P2Y1 and P2Y12 receptors play a key role in platelet activation and aggregation. Whereas the P2Y1 antagonists are at the preclinical stage, at present, the P2Y12 antagonists are the most effective treatment strategy to prevent stent thrombosis after percutaneous coronary intervention. Despite an increasing number of publications on PEVs, the mechanisms underlying their formation, including the role of purinergic receptors in this process, remain an active research field. Here, we outline the clinical relevance of PEVs in cardiovascular disease, summarize the role and downstream signalling of P2Y receptors in platelet activation, and discuss the available evidence regarding their role in PEV formation.<\/jats:p>","DOI":"10.3390\/ijms21176065","type":"journal-article","created":{"date-parts":[[2020,8,23]],"date-time":"2020-08-23T21:28:06Z","timestamp":1598218086000},"page":"6065","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Role of P2Y Receptors in Platelet Extracellular Vesicle Release"],"prefix":"10.3390","volume":"21","author":[{"given":"Aleksandra","family":"G\u0105secka","sequence":"first","affiliation":[{"name":"1st Chair and Department of Cardiology, Medical University of Warsaw, 02-106 Warsaw, Poland"},{"name":"Laboratory Experimental Clinical Chemistry, and Vesicle Observation Center, Amsterdam UMC, University of Amsterdam, 1012 WX Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwester","family":"Rogula","sequence":"additional","affiliation":[{"name":"1st Chair and Department of Cardiology, Medical University of Warsaw, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceren","family":"Eyileten","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7826-4458","authenticated-orcid":false,"given":"Marek","family":"Postu\u0142a","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi\u0142osz J.","family":"Jaguszewski","sequence":"additional","affiliation":[{"name":"1st Department of Cardiology, Medical University of Gdansk, 80-210 Gda\u0144sk, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Kochman","sequence":"additional","affiliation":[{"name":"1st Chair and Department of Cardiology, Medical University of Warsaw, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3693-8741","authenticated-orcid":false,"given":"Tomasz","family":"Mazurek","sequence":"additional","affiliation":[{"name":"1st Chair and Department of Cardiology, Medical University of Warsaw, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5671-3400","authenticated-orcid":false,"given":"Rienk","family":"Nieuwland","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Pharmacology, Centre for Preclinical Research and Technology, Medical University of Warsaw, 02-097 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof J.","family":"Filipiak","sequence":"additional","affiliation":[{"name":"1st Chair and Department of Cardiology, Medical University of Warsaw, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,8,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-2005-916671","article-title":"Platelet: Physiology and Biochemistry","volume":"1","author":"Jurk","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000214317","article-title":"Production of prostacyclin by vascular endothelial cells","volume":"8","author":"Willems","year":"1979","journal-title":"Pathophysiol. Haemost. Thromb."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3109\/09537104.2010.497231","article-title":"P2Y12 receptor in platelet activation","volume":"22","author":"Kim","year":"2011","journal-title":"Platelets"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.biocel.2010.07.012","article-title":"Platelets: Pleiotropic roles in atherogenesis and atherothrombosis","volume":"42","author":"Linden","year":"2010","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1161\/ATVBAHA.115.303395","article-title":"Purinergic Receptors in Thrombosis and Inflammation","volume":"35","author":"Hechler","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/5584_2017_91","article-title":"An update on P2Y 13 receptor signalling and function","volume":"1051","author":"Ortega","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fphar.2018.00037","article-title":"Biology of Platelet Purinergic Receptors and Implications for Platelet Heterogeneity","volume":"9","author":"Ravid","year":"2018","journal-title":"Front. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1160\/TH07-10-0601","article-title":"Detection of P2Y (14) protein in platelets and investigation of the role of P2Y (14) in platelet function in comparison with the EP (3) receptor","volume":"100","author":"Dovlatova","year":"2008","journal-title":"Thromb Haemost."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.vph.2017.12.063","article-title":"UDP-sugars activate P2Y14 receptors to mediate vasoconstriction of the porcine coronary artery","volume":"103","author":"Abbas","year":"2018","journal-title":"Vascul. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1160\/TH07-11-0673","article-title":"P2 receptors, platelet function and pharmacological implications","volume":"99","author":"Gachet","year":"2008","journal-title":"Thromb. Haemost."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/ATVBAHA.115.306885","article-title":"Synergistic inhibition of both P2Y1 and P2Y12 adenosine diphosphate receptors as novel approach to rapidly attenuate platelet-mediated thrombosis","volume":"36","author":"Gremmel","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"39","author":"Valgimigli","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.blre.2014.10.003","article-title":"Platelet secretion: From haemostasis to wound healing and beyond","volume":"29","author":"Golebiewska","year":"2015","journal-title":"Blood Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1124\/pr.112.005983","article-title":"Classification, Functions, and Clinical Relevance of Extracellular Vesicles","volume":"64","author":"Boing","year":"2012","journal-title":"Pharmacol. Rev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1182\/blood.V94.11.3791","article-title":"Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exozomes Derived from Exocytosis of multivascular bodies and alpha-granules","volume":"94","author":"Heijnen","year":"1999","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1080\/09537104.2016.1254174","article-title":"Platelet extracellular vesicles as biomarkers for arterial thrombosis","volume":"28","author":"Gasecka","year":"2017","journal-title":"Platelets"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijcard.2016.10.007","article-title":"Cell-derived microvesicles in cardiovascular diseases and antiplatelet therapy monitoring \u2014 A lesson for future trials? Current evidence, recent progresses and perspectives of clinical application","volume":"226","author":"Tomaniak","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5603\/KP.a2017.0178","article-title":"Extracellular vesicles in post-infarct ventricular remodelling","volume":"76","author":"Nieuwland","year":"2018","journal-title":"Kardiol. Pol."},{"key":"ref_19","unstructured":"Michelson, A., Cattaneo, M., Frelinger, A., and Newman, P. (2019). Platelet-derived extracellular vesicles. Platelets, Academic Press, Elsevier. [4th ed.]."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Sun, C., Zhao, W.-B., Chen, Y., and Hu, H.-Y. (2016). Higher plasma concentrations of platelet microparticles in patients with acute coronary syndrome: A systematic review and meta-analysis. Can. J. Cardiol., 32.","DOI":"10.1016\/j.cjca.2016.02.052"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/jth.14689","article-title":"Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel","volume":"18","author":"Gasecka","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7150\/ijms.28580","article-title":"Platelet Reactivity And Circulating Platelet-Derived Microvesicles Are Differently Affected By P2Y 12 Receptor Antagonists","volume":"16","author":"Stepien","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/09537104.2010.520373","article-title":"Clearance of platelet microparticles in vivo","volume":"22","author":"Rank","year":"2011","journal-title":"Platelets"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1055\/s-0035-1556047","article-title":"Clinical Significance of Tissue Factor-Exposing Microparticles in Arterial and Venous Thrombosis","volume":"41","author":"Bleker","year":"2015","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.CIR.103.5.718","article-title":"Key Role of the P2Y1 Receptor in Tissue Factor--Induced Thrombin-Dependent Acute Thromboembolism: Studies in P2Y1-Knockout Mice and Mice Treated With a P2Y1 Antagonist","volume":"103","author":"Freund","year":"2001","journal-title":"Circulation"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1538-7836.2003.00003.x","article-title":"Lineage-specific overexpression of the P2Y1 receptor induces platelet hyper-reactivity in transgenic mice","volume":"1","author":"Hechler","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1160\/TH12-11-0853","article-title":"Contact-and agonist-regulated microvesiculation of human platelets","volume":"110","author":"Zhang","year":"2013","journal-title":"Thromb. Haemost."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.abb.2009.02.014","article-title":"Role of cAMP-dependent protein kinase in the regulation of platelet procoagulant activity","volume":"485","author":"Yan","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/ATVBAHA.109.200956","article-title":"Cellular mechanisms underlying the formation of circulating microparticles","volume":"31","author":"Morel","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2741\/2690","article-title":"Role of P2Y receptor subtypes in platelet-derived microparticle generation","volume":"13","author":"Kahner","year":"2008","journal-title":"Front Biosci."},{"key":"ref_31","unstructured":"Gasecka, A., Nieuwland, R., van der Pol, E., Hajji, N., \u0106wiek, A., Pluta, K., and Konwerski Micha\u0142and Filipiak, K.J. (2013). P2Y12 antagonist ticagrelor inhibits the release of procoagulant extracellular vesicles from activated platelets: Preliminary results. Cardiol. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1161\/01.ATV.0000092127.16125.E6","article-title":"Differential involvement of the P2Y1and P2Y12receptors in platelet procoagulant activity","volume":"23","author":"Ravanat","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/09537100410001682797","article-title":"Collagen-induced generation of platelet-derived microparticles in whole blood is dependent on ADP released from red blood cells and calcium ions","volume":"15","author":"Takano","year":"2004","journal-title":"Platelets"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"628","DOI":"10.2174\/1381612824666171213105002","article-title":"Genetic Variability of SRC Family Kinases and Its Association with Platelet Hyperreactivity and Clinical Outcomes: A Systematic Review","volume":"24","author":"Milanowski","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Biesinger, B.S., Gasecka, A., Perkmann, T., Wojta, J., Lesiak, M., Grygier, M., Eyileten, C., Postu\u0142a, M., Filipiak, K.J., and Toma, A. (2020). Inflammatory state does not affect the antiplatelet efficacy of potent P2Y12 inhibitors in ACS. Platelets, 1\u20139.","DOI":"10.1080\/09537104.2020.1766670"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/cpt.1492","article-title":"Effectiveness of antiplatelet drugs under therapeutic hypothermia: A comprehensive review","volume":"106","author":"Eyileten","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/TCRM.S152369","article-title":"Ticagrelor \u2013 toward more efficient platelet inhibition and beyond","volume":"14","author":"Kubisa","year":"2018","journal-title":"Ther. Clin. Risk Manag."},{"key":"ref_38","first-page":"730","article-title":"Can prasugrel decrease the extent of periprocedural myocardial injury during elective percutaneous coronary intervention?","volume":"127","author":"Tomaniak","year":"2017","journal-title":"Pol. Arch. Intern. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/09537100400005634","article-title":"Inhibitory effects of P2Y12 receptor antagonists on TRAP-induced platelet aggregation, procoagulant activity, microparticle formation and intracellular calcium responses in patients with acute coronary syndromes","volume":"16","author":"Behan","year":"2005","journal-title":"Platelets"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/09537100701694144","article-title":"The active metabolite of prasugrel effectively blocks the platelet P2Y12 receptor and inhibits procoagulant and pro-inflammatory platelet responses","volume":"19","author":"Judge","year":"2008","journal-title":"Platelets"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.1365-2141.1998.01056.x","article-title":"The P2Y1receptor, necessary but not sufficient to support full ADP- induced platelet aggregation, is not the target of the drug clopidogrel","volume":"103","author":"Hechler","year":"1998","journal-title":"Br. J. Haematol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.thromres.2018.05.021","article-title":"Effects of clopidogrel with or without aspirin on the generation of extracellular vesicles in the microcirculation and in venous blood: A randomized placebo controlled trial","volume":"167","author":"Traby","year":"2018","journal-title":"Thromb. Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1080\/09537100500163226","article-title":"Glycoprotein IIb\/IIIa and P2Y12 receptor antagonists yield additive inhibition of platelet aggregation, granule secretion, soluble CD40L release and procoagulant responses","volume":"16","author":"Judge","year":"2005","journal-title":"Platelets"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1253\/circj.CJ-11-1145","article-title":"Endothelial Progenitor Cell Mobilization and Platelet Microparticle Release Are Influenced by Clopidogrel Plasma Levels in Stable Coronary Artery Disease","volume":"76","author":"Pinheiro","year":"2012","journal-title":"Circ. J."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1590\/1414-431X20143628","article-title":"Effects of simvastatin\/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy","volume":"47","author":"Camargo","year":"2014","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/09537104.2019.1648780","article-title":"The association of P2Y12 inhibitors with pro-coagulatory extracellular vesicles and microRNAs in stable coronary artery disease","volume":"31","author":"Haller","year":"2020","journal-title":"Platelets"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"14586","DOI":"10.1016\/S0021-9258(18)82371-7","article-title":"Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann\u2019s thrombasthenia defect","volume":"268","author":"Gemmell","year":"1993","journal-title":"J. Biol. Chem."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/09537104.2018.1557616","article-title":"Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction","volume":"31","author":"Gasecka","year":"2018","journal-title":"Platelets"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.3389\/fphar.2019.01256","article-title":"Platelet-derived extracellular vesicles as target of antiplatelet agents. What is the evidence?","volume":"10","author":"Taus","year":"2019","journal-title":"Front. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1124\/mol.114.095711","article-title":"Nucleotides acting at P2Y receptors: Connecting structure and function","volume":"88","author":"Jacobson","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/CIRCRESAHA.117.309417","article-title":"Methodological guidelines to study extracellular vesicles","volume":"120","author":"Coumans","year":"2017","journal-title":"Circ. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/jth.13190","article-title":"Recent developments in the nomenclature, presence, isolation, detection and clinical impact of extracellular vesicles","volume":"14","author":"Gool","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1538-7836.2012.04683.x","article-title":"Single vs. swarm detection of microparticles and exosomes by flow cytometry","volume":"10","author":"Sturk","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/jth.14009","article-title":"Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation","volume":"16","author":"Sturk","year":"2018","journal-title":"J. Thromb. Haemost."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Varga, Z., van der Pol, E., P\u00e1lmai, M., Garcia-Diez, R., Gollwitzer, C., Krumrey, M., Fraikin, J.-L., Gasecka, A., Hajji, N., and van Leeuwen, T.G. (2018). Hollow organosilica beads as reference particles for optical detection of extracellular vesicles. J. Thromb. Haemost., 16.","DOI":"10.1111\/jth.14193"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1713526","DOI":"10.1080\/20013078.2020.1713526","article-title":"MIFlowCyt-EV: A framework for standardized reporting of extracellular vesicle flow cytometry experiments","volume":"9","author":"Welsh","year":"2020","journal-title":"J. Extracell. Vesicles."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/nmeth.4185","article-title":"EV-TRACK: Transparent reporting and centralizing knowledge in extracellular vesicle research","volume":"14","author":"Mestdagh","year":"2017","journal-title":"Nat. Methods."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/17\/6065\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:05:21Z","timestamp":1760177121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/17\/6065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,23]]},"references-count":58,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["ijms21176065"],"URL":"https:\/\/doi.org\/10.3390\/ijms21176065","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,23]]}}}